TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation
Abstract Osteosarcoma (OS), the most common primary malignancy of the bone, has a poor prognosis due to its high mortality rate and high potential for metastasis. Thus, it is urgently necessary to explore functional molecular targets of therapeutic strategies for osteosarcoma. Here, we reported that...
Main Authors: | Minghao Yang, Yuzhu Zhang, Guangping Liu, Ziqian Zhao, Jigang Li, Le Yang, Kui Liu, Wei Hu, Yunwei Lou, Jie Jiang, Qing Liu, Peiqing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-09-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05273-y |
Similar Items
-
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis
by: Hao Liu, et al.
Published: (2024-02-01) -
The protein arginine methyltransferase PRMT1 promotes TBK1 activation through asymmetric arginine methylation
by: Zhenzhen Yan, et al.
Published: (2021-09-01) -
Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5
by: Melody D. Fulton, et al.
Published: (2022-01-01) -
Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
by: Parisa Dashti, et al.
Published: (2023-12-01) -
Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer
by: Li-Ming Liu, et al.
Published: (2021-08-01)